CD34+ cell mobilization for allogeneic progenitor cell transplantation: Efficacy of a short course of G-CSF

Transfusion

Volumn 41, Issue 2, 2001, Pages 190-195

  De Fabritiis, Paolo ^a,b   Iori, Anna Paola ^a   Mengarelli, Andrea ^a   Gozzer, Maria ^a   Ferrazza, Giancarlo ^a   De Propris, Maria Stefania ^a   Romano, Atelda ^a   Arcese, William ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Dipto Biotecnologie Cellulari ed E   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BLOOD DONOR; CELL TRANSPLANTATION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN EXPERIMENT; LEUKAPHERESIS; MALE; NORMAL HUMAN;

ADOLESCENT; ADULT; ANTIGENS, CD34; BLOOD DONORS; BLOOD SPECIMEN COLLECTION; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; PLATELET TRANSFUSION; TIME FACTORS;

EID: 0035106971     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41020190.x     Document Type: Article

References (29)

1. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation
2. Primary transplantation of allogeneic peripheral blood progenitor cells mobilised by filgrastim (granulocyte colony-stimulating factor)
3. Transplantation of allogeneic peripheral blood stem cells mobilised by recombinant human granulocyte colony stimulating factor
4. Allogenic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantages of blood over marrow allografts
5. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation
6. Allogeneic bone marrow transplantation vs filgrastim-mobilized peripheral blood progenitor cell transplantation in patients with early leukaemia: First results of a randomized multicentre trial of the European Group for Blood and Marrow Transplantation
7. Allogenic blood stem cell transplantation: Peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and GVHD
8. Transplantation of allogeneic CD34+ blood cells
9. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias
10. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals
11. Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSF
12. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
13. Chronic graft-versus-host syndrome in man: A long term clinicopathologic study of 20 Seattle patients
14. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients
15. The place of blood stem cells in allogeneic transplantation
16. Peripheral blood stem cells for allografting
17. Allogeneic marrow reconstitution using peripheral blood stem cells: The dawn of a new era
18. Blood and marrow transplantation activity in Europe 1996
19. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: The M.D. Anderson Cancer Center experience
20. Filgrastim-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization and composition of the graft
21. Treatment of normal individuals with granulocyte colony stimulating factor: Donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells
22. Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation
23. Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF
24. Mobilization of peripheral blood progenitor cells for allogeneic transplantation: Efficacy and toxicity of a high dose rh-G-CSF regimen
25. Clinical toxicity and laboratory effects of granulocyte-colony stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors and analysis of charges for the procedures
26. Optimizing dose and scheduling of filgrastim (granulocyte colony stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers
27. Combined transplantation of allogeneic bone marrow and CD34+ blood cells
28. Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells
29. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation of resistant or relapsing acute leukemias